MCKEW JOHN C.

PrivateCIK: 1640560
Location

AUSTIN, TX

MCKEW JOHN C. (Chief Scientific Officer) reported 1 transaction at LUMOS PHARMA, INC.

Review the transaction codes below to understand the nature of each event.

InsiderMCKEW JOHN C.CIK 1640560
IssuerLUMOS PHARMA, INC.CIK 1126234
Officer· Chief Scientific Officer
Since Mar 2020
-255.14K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
9
Total transactions
255.14K disposed
Non-Derivative Transactions1

Common Stock

Direct
D · Disposition

Shares

13.15K

Price / share

Trade value

% of position

New position
12/12/2024
13.15K0.00
Total

Net shares

13.15K

Net value

$0.00

Derivative Transactions8

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

16K shares

Shares

16K

Strike price

2.84

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

16K shares

Shares

16K

Strike price

3.52

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

6.54K shares

Shares

6.54K

Strike price

2.45

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

9.58K shares

Shares

9.58K

Strike price

2.45

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

81.69K shares

Shares

81.69K

Strike price

4.82

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

65K shares

Shares

65K

Strike price

7.87

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

14K shares

Shares

14K

Strike price

10.02

Held after

0.00

Exercisable

12/12/2024

Stock Option (Right to Buy)

Direct
D · Disposition
Converts to

Common Stock

33.17K shares

Shares

33.17K

Strike price

17.35

Held after

0.00

Exercisable

12/12/2024
MCKEW JOHN C. — Insider Transaction (Form 4) Filed Dec 13, 2024 | Finecho